<DOC>
	<DOCNO>NCT02075112</DOCNO>
	<brief_summary>The purpose study determine soy supplementation chemotherapy radiation therapy decrease side effect cause treatment . Long-lasting dry mouth side effect standard treatment , test whether soy supplementation treatment may reduce symptom side effect chemoradiation .</brief_summary>
	<brief_title>Soy Isoflavone Combination With Radiation Therapy Cisplatin SCC Head Neck</brief_title>
	<detailed_description>Concurrent chemoradiation standard care locally advance squamous cell carcinoma head neck ( SCCHN ) . Improving outcome patient disease remain major challenge .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Genistein</mesh_term>
	<criteria>Biopsy proven squamous cell carcinoma head neck ( SCCHN ) Primary disease site involve oropharynx Clinical stage III IV Age ≥ 18 Karnofsky Performance Status ( KPS ) ≥ 70 Adequate bone marrow , kidney , hepatic function ( laboratory value &gt; 2 time normal limit ) Amylase ( 0160 U/L ) lipase ( 0130 U/L ) level within 1.5 time range normal Prior history SCCHN Prior history radiation head neck region KPS &lt; 70 Soy allergy Contraindication cisplatin chemotherapy plan alter reduce cisplatin therapy Any head neck cancer nonsquamous histology Any head neck subsite oropharynx ( include unknown primary site ) Patients pregnant lactate Patients may benefit surgical resection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Soy</keyword>
	<keyword>Isoflavone</keyword>
	<keyword>Radiation Therapy</keyword>
	<keyword>Cisplatin</keyword>
</DOC>